Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4319 | 1732 | 27.5 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2501 | 3444 | EOSINOPHILIC ESOPHAGITIS//HYPEREOSINOPHILIC SYNDROME//EOSINOPHILIC GASTROENTERITIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HYPEREOSINOPHILIC SYNDROME | Author keyword | 253 | 68% | 13% | 225 |
2 | CHRONIC EOSINOPHILIC LEUKEMIA | Author keyword | 76 | 85% | 2% | 40 |
3 | IDIOPATHIC HYPEREOSINOPHILIC SYNDROME | Author keyword | 76 | 77% | 3% | 51 |
4 | FIP1L1 PDGFRA | Author keyword | 45 | 80% | 2% | 28 |
5 | ENDOMYOCARDIAL FIBROSIS | Author keyword | 41 | 51% | 3% | 57 |
6 | HYPEREOSINOPHILIA | Author keyword | 37 | 41% | 4% | 71 |
7 | EOSINOPHILIA | Author keyword | 32 | 15% | 12% | 200 |
8 | 8P11 MYELOPROLIFERATIVE SYNDROME | Author keyword | 30 | 100% | 1% | 12 |
9 | EOSINOPHILIC LEUKEMIA | Author keyword | 30 | 84% | 1% | 16 |
10 | FIP1L1 PDGFR ALPHA | Author keyword | 27 | 83% | 1% | 15 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HYPEREOSINOPHILIC SYNDROME | 253 | 68% | 13% | 225 | Search HYPEREOSINOPHILIC+SYNDROME | Search HYPEREOSINOPHILIC+SYNDROME |
2 | CHRONIC EOSINOPHILIC LEUKEMIA | 76 | 85% | 2% | 40 | Search CHRONIC+EOSINOPHILIC+LEUKEMIA | Search CHRONIC+EOSINOPHILIC+LEUKEMIA |
3 | IDIOPATHIC HYPEREOSINOPHILIC SYNDROME | 76 | 77% | 3% | 51 | Search IDIOPATHIC+HYPEREOSINOPHILIC+SYNDROME | Search IDIOPATHIC+HYPEREOSINOPHILIC+SYNDROME |
4 | FIP1L1 PDGFRA | 45 | 80% | 2% | 28 | Search FIP1L1+PDGFRA | Search FIP1L1+PDGFRA |
5 | ENDOMYOCARDIAL FIBROSIS | 41 | 51% | 3% | 57 | Search ENDOMYOCARDIAL+FIBROSIS | Search ENDOMYOCARDIAL+FIBROSIS |
6 | HYPEREOSINOPHILIA | 37 | 41% | 4% | 71 | Search HYPEREOSINOPHILIA | Search HYPEREOSINOPHILIA |
7 | EOSINOPHILIA | 32 | 15% | 12% | 200 | Search EOSINOPHILIA | Search EOSINOPHILIA |
8 | 8P11 MYELOPROLIFERATIVE SYNDROME | 30 | 100% | 1% | 12 | Search 8P11+MYELOPROLIFERATIVE+SYNDROME | Search 8P11+MYELOPROLIFERATIVE+SYNDROME |
9 | EOSINOPHILIC LEUKEMIA | 30 | 84% | 1% | 16 | Search EOSINOPHILIC+LEUKEMIA | Search EOSINOPHILIC+LEUKEMIA |
10 | FIP1L1 PDGFR ALPHA | 27 | 83% | 1% | 15 | Search FIP1L1+PDGFR+ALPHA | Search FIP1L1+PDGFR+ALPHA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IDIOPATHIC HYPEREOSINOPHILIC SYNDROME | 99 | 42% | 11% | 183 |
2 | CHRONIC EOSINOPHILIC LEUKEMIA | 68 | 62% | 4% | 70 |
3 | MYELOPROLIFERATIVE VARIANT | 55 | 78% | 2% | 36 |
4 | HYPEREOSINOPHILIC SYNDROME | 53 | 31% | 8% | 144 |
5 | FIP1L1 PDGFRA FUSION | 48 | 71% | 2% | 39 |
6 | IDIOPATHIC EOSINOPHILIA | 38 | 86% | 1% | 19 |
7 | EOSINOPHILIC LEUKEMIA | 33 | 74% | 1% | 25 |
8 | EPISODIC ANGIOEDEMA | 32 | 63% | 2% | 32 |
9 | FACTOR RECEPTOR BETA | 27 | 32% | 4% | 72 |
10 | CELL MYELOPROLIFERATIVE DISORDER | 27 | 63% | 2% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The hypereosinophilic syndromes: current concepts and treatments | 2009 | 58 | 97 | 80% |
8p11 Myeloproliferative Syndrome with t(1;8)(q25;p11.2): A Case Report and Review of the Literature | 2015 | 1 | 16 | 81% |
Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review | 2013 | 8 | 62 | 89% |
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias | 2008 | 59 | 74 | 82% |
Hypereosinophilic Syndrome and Clonal Eosinophilia: Point-of-Care Diagnostic Algorithm and Treatment Update | 2010 | 53 | 63 | 62% |
THE IDIOPATHIC HYPEREOSINOPHILIC SYNDROME | 1994 | 491 | 231 | 57% |
The HP1L1-PDIGFR alpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management | 2004 | 151 | 160 | 79% |
Hypereosinophilic syndromes | 2007 | 60 | 45 | 89% |
Eosinophilia: secondary, clonal and idiopathic | 2006 | 103 | 212 | 55% |
Hypereosinophilic Syndrome: Current Approach to Diagnosis and Treatment | 2009 | 34 | 57 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SALISBURY HUMAN GENET | 9 | 67% | 0.5% | 8 |
2 | FRENCH EOSINOPHIL NETWORK | 4 | 75% | 0.2% | 3 |
3 | EOSINOPHIL PATHOL UNIT | 3 | 57% | 0.2% | 4 |
4 | CELL BIOL EXPT PATHOL SECT | 2 | 67% | 0.1% | 2 |
5 | SEKT STAMMZELL IMMUNTHER IE | 2 | 67% | 0.1% | 2 |
6 | UNIV KLIN MED 3 | 2 | 67% | 0.1% | 2 |
7 | WESTERN REG GENET | 2 | 50% | 0.2% | 3 |
8 | FRONTIER LIFELINE | 1 | 100% | 0.1% | 2 |
9 | GENET HEMATOPATHOL | 1 | 100% | 0.1% | 2 |
10 | UNITE MEXP UCL 74 30 | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000134520 | EOSINOPHILIC CYSTITIS//EOSINOPHILIC CHOLANGITIS//EOSINOPHILIC CHOLECYSTITIS |
2 | 0.0000109951 | CHURG STRAUSS SYNDROME//ALLERGIC GRANULOMATOUS ANGIITIS//EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS |
3 | 0.0000103083 | CHRONIC EOSINOPHILIC PNEUMONIA//ACUTE EOSINOPHILIC PNEUMONIA//EOSINOPHILIC PNEUMONIA |
4 | 0.0000097715 | EOSINOPHILIC CELLULITIS//WELLS SYNDROME//FLAME FIGURES |
5 | 0.0000096821 | EOSINOPHILS//EOSINOPHIL//TUMOR ASSOCIATED TISSUE EOSINOPHILIA |
6 | 0.0000067269 | EOSINOPHILIA MYALGIA SYNDROME//EOSINOPHILIC FASCIITIS//TOXIC OIL SYNDROME |
7 | 0.0000052338 | INTERLEUKIN 5//IL 5//INTERLEUKIN 5 RECEPTOR |
8 | 0.0000050351 | EOSINOPHILIC ESOPHAGITIS//EOSINOPHILIC GASTROENTERITIS//EOSINOPHILIC OESOPHAGITIS |
9 | 0.0000046363 | MASTOCYTOSIS//SYSTEMIC MASTOCYTOSIS//URTICARIA PIGMENTOSA |
10 | 0.0000040674 | EOSINOPHILIC SYNOVITIS//ANTIPROTOZOAL THERAPY//CHARCOT LEYDEN |